{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:19:08Z","timestamp":1786994348601,"version":"build-2736575974"},"reference-count":94,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.molmed.2020.02.007","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T01:18:47Z","timestamp":1585185527000},"page":"639-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Priming the Proteasome to Protect against Proteotoxicity"],"prefix":"10.1016","volume":"26","author":[{"given":"Xuejun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2020.02.007_bb0005","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.molmed.2019.03.005","article-title":"Proteostasis and beyond: ATF6 in ischemic disease","volume":"25","author":"Glembotski","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2020.02.007_bb0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/CIRCRESAHA.112.268706","article-title":"Posttranslational modification and quality control","volume":"112","author":"Wang","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.007_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yjmcc.2013.12.015","article-title":"Proteotoxicity: an underappreciated pathology in cardiac disease","volume":"71","author":"Sandri","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCRESAHA.110.230607","article-title":"Perturbation of cullin deneddylation via conditional Csn8 ablation impairs the ubiquitin-proteasome system and causes cardiomyocyte necrosis and dilated cardiomyopathy in mice","volume":"108","author":"Su","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.007_bb0025","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/CIRCULATIONAHA.111.048934","article-title":"COP9 signalosome regulates autophagosome maturation","volume":"124","author":"Su","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.007_bb0030","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/CIRCULATIONAHA.107.750232","article-title":"Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure","volume":"117","author":"Pattison","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.007_bb0035","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41467-018-03509-0","article-title":"A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers","volume":"9","author":"Thibaudeau","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2020.02.007_bb0040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.yjmcc.2005.12.011","article-title":"Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes","volume":"40","author":"Liu","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0045","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1096\/fj.05-4869fje","article-title":"Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts","volume":"20","author":"Liu","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2020.02.007_bb0050","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/01.RES.0000189262.92896.0b","article-title":"Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake","volume":"97","author":"Chen","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.007_bb0055","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/CIRCHEARTFAILURE.113.000338","article-title":"The COP9 signalosome is required for autophagy, proteasome-mediated proteolysis, and cardiomyocyte survival in adult mice","volume":"6","author":"Su","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.molmed.2020.02.007_bb0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molmed.2017.11.006","article-title":"Targeting the 26S proteasome to protect against proteotoxic diseases","volume":"24","author":"Myeku","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2020.02.007_bb0065","doi-asserted-by":"crossref","first-page":"10132","DOI":"10.1073\/pnas.0401900101","article-title":"Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis","volume":"101","author":"Sanbe","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.02.007_bb0070","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jtcvs.2016.06.017","article-title":"Disruption of desmin-mitochondrial architecture in patients with regurgitant mitral valves and preserved ventricular function","volume":"152","author":"Ahmed","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.molmed.2020.02.007_bb0075","doi-asserted-by":"crossref","first-page":"16594","DOI":"10.1038\/s41598-018-34808-7","article-title":"Amyloid precursor protein-fragments-containing inclusions in cardiomyocytes with basophilic degeneration and its association with cerebral amyloid angiopathy and myocardial fibrosis","volume":"8","author":"Kramer","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2020.02.007_bb0080","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1161\/CIRCRESAHA.117.312082","article-title":"Desmin phosphorylation triggers preamyloid oligomers formation and myocyte dysfunction in acquired heart failure","volume":"122","author":"Rainer","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.007_bb0085","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.08.073","article-title":"Abeta amyloid pathology affects the hearts of patients with Alzheimer\u2019s disease: mind the heart","volume":"68","author":"Troncone","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/CIRCRESAHA.118.313563","article-title":"Getting to the heart of Alzheimer disease","volume":"124","author":"Tublin","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.007_bb0095","doi-asserted-by":"crossref","first-page":"H1283","DOI":"10.1152\/ajpheart.00249.2012","article-title":"The ubiquitin proteasome system in human cardiomyopathies and heart failure","volume":"304","author":"Day","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/hh1301.092688","article-title":"Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice","volume":"89","author":"Wang","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.007_bb0105","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/01.CIR.103.19.2402","article-title":"Mouse model of desmin-related cardiomyopathy","volume":"103","author":"Wang","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.007_bb0110","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.107.763870","article-title":"Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy","volume":"117","author":"Tannous","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.007_bb0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tcm.2014.10.013","article-title":"Reviving the protein quality control system: therapeutic target for cardiac disease in the elderly","volume":"25","author":"Meijering","year":"2015","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.molmed.2020.02.007_bb0120","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1172\/JCI70877","article-title":"Enhanced autophagy ameliorates cardiac proteinopathy","volume":"123","author":"Bhuiyan","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2020.02.007_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40035-017-0072-x","article-title":"The role of exosomes in the pathogenesis of Alzheimer\u2019s disease","volume":"6","author":"Xiao","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.molmed.2020.02.007_bb0130","doi-asserted-by":"crossref","first-page":"H304","DOI":"10.1152\/ajpheart.00145.2017","article-title":"Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy","volume":"313","author":"Wang","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yjmcc.2008.03.025","article-title":"Protein quality control and degradation in cardiomyocytes","volume":"45","author":"Wang","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2013.11.006","article-title":"Proteasomal and lysosomal protein degradation and heart disease","volume":"71","author":"Wang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0145","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.200709080","article-title":"Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice","volume":"180","author":"Wang","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145333","article-title":"Reduced levels of proteasome products in a mouse striatal cell model of Huntington\u2019s disease","volume":"10","author":"Dasgupta","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2020.02.007_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10571-013-0022-9","article-title":"The proteasome function reporter GFPu accumulates in young brains of the APPswe\/PS1dE9 Alzheimer\u2019s disease mouse model","volume":"34","author":"Liu","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0160","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neurobiolaging.2008.07.008","article-title":"Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome","volume":"31","author":"Emmanouilidou","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molmed.2020.02.007_bb0165","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/17482968.2012.686511","article-title":"Impaired proteasome function in sporadic amyotrophic lateral sclerosis","volume":"13","author":"Kabashi","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.molmed.2020.02.007_bb0170","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","article-title":"Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature","volume":"112","author":"Argyriou","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2020.02.007_bb0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/pmic.200390029","article-title":"Hyperubiquitination of proteins in dilated cardiomyopathy","volume":"3","author":"Weekes","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.molmed.2020.02.007_bb0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12881-016-0267-5","article-title":"A substitution mutation in cardiac ubiquitin ligase, FBXO32, is associated with an autosomal recessive form of dilated cardiomyopathy","volume":"17","author":"Al-Hassnan","year":"2016","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.molmed.2020.02.007_bb0185","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCRESAHA.112.270207","article-title":"Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy","volume":"111","author":"Chen","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.007_bb0190","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/hmg\/ddz032","article-title":"Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24","volume":"28","author":"Hedberg-Oldfors","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2020.02.007_bb0195","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2017.09.1096","article-title":"Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1","volume":"70","author":"Chang","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0200","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1096\/fj.10-160895","article-title":"Enhancement of proteasome function by PA28\u03b1 overexpression protects against oxidative stress","volume":"25","author":"Li","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2020.02.007_bb0205","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1172\/JCI45709","article-title":"Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia\/reperfusion injury in mice","volume":"121","author":"Li","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2020.02.007_bb0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2016.11.013","article-title":"Cardiac proteasome functional insufficiency plays a pathogenic role in diabetic cardiomyopathy","volume":"102","author":"Li","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0215","doi-asserted-by":"crossref","first-page":"H551","DOI":"10.1152\/ajpheart.00771.2012","article-title":"Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure","volume":"305","author":"Rajagopalan","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0220","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2017.04.023","article-title":"The logic of the 26S proteasome","volume":"169","author":"Collins","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2020.02.007_bb0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yjmcc.2013.10.008","article-title":"Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond","volume":"71","author":"Cui","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0230","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cell.2019.03.035","article-title":"Protein sequence editing of SKN-1A\/Nrf1 by peptide:N-glycanase controls proteasome gene expression","volume":"177","author":"Lehrbach","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2020.02.007_bb0235","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41580-018-0040-z","article-title":"Regulation of proteasome assembly and activity in health and disease","volume":"19","author":"Rousseau","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0240","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncb3289","article-title":"Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis","volume":"18","author":"Guo","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0245","doi-asserted-by":"crossref","first-page":"E7176","DOI":"10.1073\/pnas.1522332112","article-title":"cAMP-induced phosphorylation of 26S proteasomes on Rpn6\/PSMD11 enhances their activity and the degradation of misfolded proteins","volume":"112","author":"Lokireddy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.02.007_bb0250","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCULATIONAHA.113.001971","article-title":"Protein kinase G positively regulates proteasome-mediated degradation of misfolded proteins","volume":"128","author":"Ranek","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.007_bb0255","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0003-9861(90)90613-4","article-title":"Phosphorylation of the multicatalytic proteinase complex from bovine pituitaries by a copurifying cAMP-dependent protein kinase","volume":"283","author":"Pereira","year":"1990","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.molmed.2020.02.007_bb0260","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.RES.0000237389.40000.02","article-title":"Regulation of murine cardiac 20S proteasomes: role of associating partners","volume":"99","author":"Zong","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.007_bb0265","doi-asserted-by":"crossref","first-page":"22460","DOI":"10.1074\/jbc.M702439200","article-title":"Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6","volume":"282","author":"Zhang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2020.02.007_bb0270","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1073\/pnas.1809254116","article-title":"26S Proteasomes are rapidly activated by diverse hormones and physiological states that raise cAMP and cause Rpn6 phosphorylation","volume":"116","author":"VerPlank","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.02.007_bb0275","article-title":"PDE1 inhibition facilitates proteasomal degradation of misfolded proteins and protects against cardiac proteinopathy","volume":"5","author":"Zhang","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2020.02.007_bb0280","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1074\/mcp.M800064-MCP200","article-title":"Revealing the dynamics of the 20 S proteasome phosphoproteome: a combined CID and electron transfer dissociation approach","volume":"7","author":"Lu","year":"2008","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.molmed.2020.02.007_bb0285","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.yjmcc.2008.11.001","article-title":"PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts","volume":"46","author":"Asai","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0290","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.110.222364","article-title":"Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy","volume":"107","author":"Drews","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.007_bb0295","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2014.01.017","article-title":"Muscarinic 2 receptors modulate cardiac proteasome function in a protein kinase G-dependent manner","volume":"69C","author":"Ranek","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0300","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/01.RES.0000252342.61447.a2","article-title":"Heart failure and protein quality control","volume":"99","author":"Wang","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.007_bb0305","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41467-018-04117-8","article-title":"Increased proteasomal activity supports photoreceptor survival in inherited retinal degeneration","volume":"9","author":"Lobanova","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2020.02.007_bb0310","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.acvd.2016.02.004","article-title":"Cyclic nucleotide phosphodiesterases in heart and vessels: a therapeutic perspective","volume":"109","author":"Bobin","year":"2016","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.molmed.2020.02.007_bb0315","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm.4011","article-title":"Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling","volume":"22","author":"Myeku","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2020.02.007_bb0320","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/jnen\/nlw043","article-title":"Protective effects of forskolin on behavioral deficits and neuropathological changes in a mouse model of cerebral amyloidosis","volume":"75","author":"Owona","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0325","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hipo.22128","article-title":"PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington\u2019s disease mouse model","volume":"23","author":"Giralt","year":"2013","journal-title":"Hippocampus"},{"key":"10.1016\/j.molmed.2020.02.007_bb0330","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in Huntington\u2019s disease models","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.molmed.2020.02.007_bb0335","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.trsl.2017.11.004","article-title":"Cilostazol, a phosphodiesterase 3 inhibitor, activates proteasome-mediated proteolysis and attenuates tauopathy and cognitive decline","volume":"193","author":"Schaler","year":"2018","journal-title":"Transl. Res."},{"key":"10.1016\/j.molmed.2020.02.007_bb0340","doi-asserted-by":"crossref","first-page":"11469","DOI":"10.1038\/s41598-017-11664-5","article-title":"Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells","volume":"7","author":"Hollerhage","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2020.02.007_bb0345","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3233\/JAD-161006","article-title":"Sildenafil improves vascular and metabolic function in patients with Alzheimer\u2019s disease","volume":"60","author":"Sheng","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.molmed.2020.02.007_bb0350","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12883-017-0800-y","article-title":"Cilostazol as an add-on therapy for patients with Alzheimer\u2019s disease in Taiwan: a case control study","volume":"17","author":"Tai","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0355","article-title":"Phosphodiesterase III inhibitors for heart failure","volume":"1","author":"Amsallem","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.molmed.2020.02.007_bb0360","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2016.03.014","article-title":"Novel approaches to targeting PDE3 in cardiovascular disease","volume":"163","author":"Movsesian","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2020.02.007_bb0365","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.molmed.2020.02.007_bb0370","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/164_2016_82","article-title":"Cardiac phosphodiesterases and their modulation for treating heart disease","volume":"243","author":"Kim","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0375","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-4939-8706-1_20","article-title":"Exploring the regulation of proteasome function by subunit phosphorylation","volume":"1844","author":"VerPlank","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0380","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality: the Framingham Study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am. Heart J."},{"key":"10.1016\/j.molmed.2020.02.007_bb0385","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2020.02.007_bb0390","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41586-019-0895-y","article-title":"PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress","volume":"566","author":"Ranek","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2020.02.007_bb0395","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004740","article-title":"Prevention of PKG-1alpha oxidation suppresses antihypertrophic\/antifibrotic effects from PDE5 inhibition but not sGC stimulation","volume":"11","author":"Nakamura","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.molmed.2020.02.007_bb0400","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"Tsai","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2020.02.007_bb0405","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2020.02.007_bb0410","doi-asserted-by":"crossref","first-page":"32749","DOI":"10.1074\/jbc.M703173200","article-title":"Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes","volume":"282","author":"Vandeput","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2020.02.007_bb0415","article-title":"Roles of PDE1 in pathological cardiac remodeling and dysfunction","volume":"5","author":"Chen","year":"2018","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.molmed.2020.02.007_bb0420","doi-asserted-by":"crossref","first-page":"E7116","DOI":"10.1073\/pnas.1607728113","article-title":"PDE1C deficiency antagonizes pathological cardiac remodeling and dysfunction","volume":"113","author":"Knight","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.02.007_bb0425","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/CIRCRESAHA.109.198515","article-title":"Role of Ca2+\/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy","volume":"105","author":"Miller","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.007_bb0430","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/CIRCULATIONAHA.117.030490","article-title":"Acute enhancement of cardiac function by phosphodiesterase Type 1 inhibition","volume":"138","author":"Hashimoto","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.007_bb0435","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1146\/annurev.pharmtox.41.1.751","article-title":"Compartmentation of G protein-coupled signaling pathways in cardiac myocytes","volume":"41","author":"Steinberg","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0440","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1085\/jgp.201311083","article-title":"Cyclic AMP compartments and signaling specificity: role of cyclic nucleotide phosphodiesterases","volume":"143","author":"Conti","year":"2014","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0445","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-pharmtox-010716-104756","article-title":"Nanodomain regulation of cardiac cyclic nucleotide signaling by phosphodiesterases","volume":"57","author":"Kokkonen","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0450","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1172\/JCI38027","article-title":"Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease","volume":"119","author":"Goldfarb","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2020.02.007_bb0455","doi-asserted-by":"crossref","first-page":"33235","DOI":"10.1074\/jbc.274.47.33235","article-title":"The cardiomyopathy and lens cataract mutation in alphaB-crystallin alters its protein structure, chaperone activity, and interaction with intermediate filaments in vitro","volume":"274","author":"Perng","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2020.02.007_bb0460","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1073\/pnas.96.11.6137","article-title":"Mutation R120G in alphaB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function","volume":"96","author":"Bova","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.02.007_bb0465","doi-asserted-by":"crossref","first-page":"H1220","DOI":"10.1152\/ajpheart.00601.2011","article-title":"Desmin-related cardiomyopathy: an unfolding story","volume":"301","author":"McLendon","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.molmed.2020.02.007_bb0470","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1097-2765(04)00151-0","article-title":"Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins","volume":"14","author":"Venkatraman","year":"2004","journal-title":"Mol. Cell"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491420300642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491420300642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:21:00Z","timestamp":1761463260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491420300642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":94,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1471491420300642"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2020.02.007","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Priming the Proteasome to Protect against Proteotoxicity","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2020.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}